SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17189692
Source:
http://linkedlifedata.com/resource/pubmed/id/17189692
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0243077
,
umls-concept:C0253457
,
umls-concept:C1527148
pubmed:issue
5
pubmed:dateCreated
2007-2-19
pubmed:abstractText
A new class of bicyclic pyrrolopyrimidine-based Janus kinase 3 (JAK-3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK-3.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9107377
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 2
,
http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 3
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0960-894X
pubmed:author
pubmed-author:BooklandRoger GRG
,
pubmed-author:BrugelTodd ATA
,
pubmed-author:CabreraEd JEJ
,
pubmed-author:ChenJackJ
,
pubmed-author:ClarkMichael PMP
,
pubmed-author:DavisJan RJR
,
pubmed-author:DeBiswanathB
,
pubmed-author:EaswaranVijayV
,
pubmed-author:GeorgeKelly MKM
,
pubmed-author:GolebiowskiAdamA
,
pubmed-author:LaufersweilerMatthew JMJ
,
pubmed-author:LaughlinSteven KSK
,
pubmed-author:LeeWenlinW
,
pubmed-author:MaierJennifer AJA
,
pubmed-author:SabatMark PMP
,
pubmed-author:ThakurKumar DKD
,
pubmed-author:VanRensJohn CJC
,
pubmed-author:WebsterMark EME
,
pubmed-author:ZhangGeorgeG
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1250-3
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17189692-Autoimmune Diseases
,
pubmed-meshheading:17189692-Cell Line, Tumor
,
pubmed-meshheading:17189692-Cell Proliferation
,
pubmed-meshheading:17189692-Humans
,
pubmed-meshheading:17189692-Immunity
,
pubmed-meshheading:17189692-Janus Kinase 2
,
pubmed-meshheading:17189692-Janus Kinase 3
,
pubmed-meshheading:17189692-Pyrimidines
,
pubmed-meshheading:17189692-Pyrroles
,
pubmed-meshheading:17189692-Structure-Activity Relationship
pubmed:year
2007
pubmed:articleTitle
Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3).
pubmed:affiliation
Procter and Gamble Pharmaceuticals, Health Care Research Center, 8700 Mason-Montgomery Road, Mason, OH 45040, USA. mclark@metastatix.com
pubmed:publicationType
Journal Article